Table 2.
1e | 13 | 14a | 14d | 14h | 20 | 24 | 26 | 27 | 59 | 79 | |
Human | S | E | K | R | E | S | I | M | S | L | I |
Murine | L | K | T | K | D | W | K | I | A | I | V |
90 | 106 | 126 | 127 | 129 | 129a | 131 | 145 | 149a | 149c | 149d | |
Human | I | M | R | E | A | A | Q | K | A | V | G |
Murine | V | L | K | Q | V | T | R | R | T | I | N |
149e | 150 | 170 | 184a | 186 | 186a | 186b | 186c | 222 | 236 | ||
Human | K | G | D | Y | P | D | E | G | D | K | |
Murine | E | I | A | F | V | N | D | T | K | R |
Replacements in italic (9 total) indicate non-conservative charge substitutions. The thrombin chimera was constructed by replacing residues 184a, 186, 186a, 186b, 186c and 222 in human thrombin with those of the murine enzyme.